consolidated revenues of $num-one billion increased num-two% above the prior year.
second quarter adjusted earnings per diluted share was $num-one, an increase of num-two%, compared to the prior year.
consolidated revenues of $num-one billion increased num-two% above the prior year.
as a result of our second quarter performance our confidence in the second half of the fiscal year and mckesson's continue to role in the covid response efforts, we are raising our guidance range for fiscal year-seven adjusted earnings per diluted share from $num-one to $num-two to a new range of $num-three to $num-four.
as a result of our strong first half performance and our outlook for the remainder of the year, we are raising our previous adjusted earnings per share guidance range for fiscal year-seven to $num-one to $num-two, which is up from our previous range of $num-three to $num-four.
additionally, fiscal year-seven adjusted earnings per diluted share guidance includes $num-one to $num-two of impacts attributable to the following items: $num-three to $num-four related to the us governments covid vaccine distribution, which is an increase from the previous range of $num-five to $num-six; $num-seven to $num-eight related to the kitting storage and distribution of ancillary supplies, an increase from the previous range of $num-three to $num-four as discussed at recent conference; $num-three to $num-nine related to covid tests impairments for ppe related products; and approximately $num-ten from gains or losses associated with mckesson ventures equity investments within our corporate segment year-to-date.